系统性红斑狼疮妊娠患者血清可溶性Flt1与胎盘生长因子纵向变化分析
该研究分析了163例系统性红斑狼疮(SLE)妊娠患者共527份血样本中可溶性Flt1(sFlt1)、胎盘生长因子(PlGF)及sFlt1:PlGF比值的纵向变化轨迹。结果显示,发生子痫前期(PE)的患者sFlt1水平及sFlt1:PlGF比值更高、PlGF水平更低,且PlGF降低和sFlt1:PlGF比值升高在孕中期初即可检测到;SLE疾病活动性未干扰这些血管生成标志物的纵向变化。
要点
- 发生PE的SLE妊娠患者sFlt1水平及sFlt1:PlGF比值更高、PlGF水平更低。
- PE患者PlGF持续低水平和sFlt1:PlGF比值升高在孕中期初即可检测到。
- SLE疾病活动性未干扰sFlt1、PlGF及sFlt1:PlGF比值的纵向变化。
核心结论
- 发生PE的SLE妊娠患者sFlt1水平及sFlt1:PlGF比值更高、PlGF水平更低,后两项变化在孕中期初、临床表现出现前即可检测到。
- SLE疾病活动性未干扰这些血管生成标志物的纵向变化。
研究设计与样本
- 纳入163例SLE妊娠患者,在孕14-18、24-26、30-32、34-36和38-40周采集血样本共527份,存于-80°C检测sFlt1、PlGF及sFlt1:PlGF比值。
- 患者分为疾病不活动组(SLEPDAI<4)、疾病活动组(SLEPDAI≥4)和子痫前期(PE)组,计算各组中位数和四分位距,并使用随机效应线性模型分析。
主要发现
- 全部患者中疾病不活动109例(66.9%)、疾病活动33例(20.2%)、疾病不活动合并PE 21例(12.9%)。
- 探索性分析中,PE患者sFlt1平均血清水平和sFlt1:PlGF比值高于疾病不活动和疾病活动SLE患者,PlGF水平低于后者(P=0.01至P<0.001)。
- 随机效应线性模型显示,疾病不活动组与疾病活动组间这些血管生成标志物的平均血清水平无显著差异。
- PE患者自第24周起sFlt1水平明显升高、自第14周起PlGF水平持续低值、孕期sFlt1:PlGF比值进行性升高,与无PE组相比差异均有统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study analyzed longitudinal trajectories of soluble Flt1 (sFlt1) levels, placenta growth factor (PlGF) levels, and sFlt1:PlGF ratios in a cohort of pregnant patients with systemic lupus erythematosus (SLE). METHODS: Blood samples were collected (14-18, 24-26, 30-32, 34-36, and 38-40 weeks), stored at -80°C, and evaluated for serum levels of sFlt1, PlGF, and sFlt1:PlGF ratios. Patients were classified as inactive SLE (Systemic Lupus Erythematosus Pregnancy Disease Activity Index [SLEPDAI] <4), active disease (SLEPDAI ≥4), or preeclampsia (PE). Medians and interquartile ranges were calculated for each group, and linear models with random effects were used. RESULTS: A total of 527 samples were obtained from 163 patients, and all patients were subsequently classified as having inactive disease (109 patients [66.9%]), active disease (33 patients [20.2%]), and inactive disease with PE (21 patients [12.9%]). In exploratory analysis, patients with PE had higher mean serum levels of sFlt1 and sFlt1:PlGF ratios and lower PlGF levels than patients with inactive and active SLE (P = 0.01 to P < 0.001). Using linear models with random effects, there was no significant differences in mean serum levels of these angiogenic markers comparing inactive and active disease. Patients with PE showed a marked increase in sFlt1 levels from the 24th week, constantly low PlGF levels from the 14th week, and progressive increase of sFlt1:PlGF ratio during pregnancy. All these differences were statistically significant compared to the groups without PE. CONCLUSION: Pregnant patients with SLE who developed PE had higher sFlt1 levels and sFlt1:PlGF ratios and lower PlGF levels, and these last two changes were detected at the beginning of second trimester, before clinical manifestation. SLE activity did not interfere with longitudinal behavior of these angiogenic markers.
引用
- de Jesús NR, de Jesús GR, Lacerda MI, et al. Analysis of the Longitudinal Behavior of Serum Levels of Soluble Flt1 and Placental Growth Factor in Pregnant Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2025. PMID: 40176387. doi:10.1002/acr.25536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。